Elevate your local knowledge
Sign up for the iNFOnews newsletter today!

NEW BRUNSWICK, N.J. – Johnson & Johnson says fourth-quarter profit jumped 19 per cent, as prescription drug sales climbed sharply and the health care giant enjoyed a big tax benefit.
The maker of baby shampoo, biological drugs and medical devices says fourth-quarter net income was $3.52 billion, or $1.23 per share, up from $2.57 billion, or 91 cents per share, a year earlier.
Excluding one-time items, net income was $3.56 billion, or $1.24 per share.
Revenue totalled $18.36 billion, up 4.5 per cent from $17.56 billion a year ago.
Analysts surveyed by FactSet were expecting, on average, earnings per share of $1.20 and revenue of $17.94 billion.
The company, based in New Brunswick, N.J., says it expects earnings per share of $5.75 to $5.85 in 2014. That’s up from $4.81 per share earned in 2013.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.